- Previous Close
10.05 - Open
10.29 - Bid 10.04 x 100
- Ask 10.13 x 100
- Day's Range
10.17 - 10.17 - 52 Week Range
9.95 - 10.85 - Volume
2 - Avg. Volume
77,379 - Market Cap (intraday)
250.007M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
www.oaktreeacquisitioncorp.com/oac-iii--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: OACC
View MorePerformance Overview: OACC
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OACC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OACC
View MoreValuation Measures
Market Cap
248.53M
Enterprise Value
247.19M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
2.66M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--